| Business Name: |
Acea Biosciences Inc |
| Contact Person: |
James P O'connell |
| Address: |
6779 Mesa Ridge Road # 100, San Diego, California 92121 |
| Phone Number: |
(858) 724-0928 |
| Website Address: |
aceabio.com |
| Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
| Founding Year: |
2003 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Commercial Medical Research |
| SIC Code: |
8731 |
| NAICS Code: |
541712 |
| Share This Business: |
|
| Related Businesses: |
Medivas LLC - San Diego, CA 92121
Bio-Quant Inc - San Diego, CA 92121
Cylene Pharmaceuticals - San Diego, CA 92121
Krex Pharmaceuticals Inc - San Diego, CA 92121
Advanced Biodelivery Sciences - San Diego, CA 92121
S K S Ocular LLC - San Diego, CA 92121
Tenova Pharmaceuticals Inc - San Diego, CA 92121
Stemedica Cell Technology - San Diego, CA 92121
Gnf Commercial Systems - San Diego, CA 92121
Sage Bioventures Inc - San Diego, CA 92121
Rempex Pharmaceuticals Inc - San Diego, CA 92121
Biomedica Inc - San Diego, CA 92121
Helicon Therapeutics - San Diego, CA 92121
Celgene Research San Diego - San Diego, CA 92121
Targegen Inc - San Diego, CA 92121
Astute Medical Inc - San Diego, CA 92121
|
The company Acea Biosciences Inc provides B2B services in the form of Commercial Medical Research from its single location in California.
1 to 4 employees work for Acea Biosciences Inc, and the business now earns $1.000.000 to $2.499.999 per annum.
Acea Biosciences Inc was launched in 2003 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Acea Biosciences Inc, please call James P O'connell with the phone number (858) 724-0928 or visit its single location at 6779 Mesa Ridge Road # 100 in San Diego, California 92121.
The location of the single location can also be found using the coordinates 32.901614,-117.174424.
Read more details about this business on the webpage aceabio.com or follow the company’s social media accounts, on Twitter and on Facebook.